Showing results (151-160 of 201) with videos related to
Sort By:
Pageof 21
Annals of Neurology|July 29, 2005
Chromosome 1p loss: a favorable prognostic factor in low-grade gliomasMichèle Kujas, Julie Lejeune, Alexandra Benouaich-Amiel, et al.Emerging Infectious Diseases|August 21, 2020
Fatal Measles Inclusion-Body Encephalitis in Adult with Untreated AIDS, FranceChristophe Rodriguez, Meriadeg Ar Gouilh, Nicolas Weiss, et al.Critical Care Medicine|January 7, 2022
Brain Biopsy for Neurological Diseases of Unknown Etiology in Critically Ill Patients: Feasibility, Safety, and Diagnostic YieldBertrand Mathon, Malory Favreau, Vincent Degos, et al.European Journal of Neurology|June 16, 2025
Quantitative Brain MRI Analysis in Neurodegenerative Langerhans Cell HistiocytosisChooyoung Baek, Lucas Rincon de la Rosa, Ilyes Aliouat, et al.Acta Neuropathologica|August 31, 2016
Prognostic impact of the 2016 WHO classification of diffuse gliomas in the French POLA cohortEmeline Tabouret, Anh Tuan Nguyen, Caroline Dehais, et al.Journal of Neuro-Oncology|December 10, 2014
VEGFA SNP rs2010963 is associated with vascular toxicity in recurrent glioblastomas and longer response to bevacizumabAnna Luisa Di Stefano, Marianne Labussiere, Giuseppe Lombardi, et al.The Journal of Molecular Diagnostics : JMD|July 9, 2018
Multiple Ways to Detect IDH2 Mutations in Angioimmunoblastic T-Cell Lymphoma from Immunohistochemistry to Next-Generation SequencingAurélie Dupuy, François Lemonnier, Virginie Fataccioli, et al.Neuro-Oncology|February 20, 2009
Molecular analysis of anaplastic oligodendroglial tumors in a prospective randomized study: A report from EORTC study 26951Mathilde C M Kouwenhoven, Thierry Gorlia, Johan M Kros, et al.The Oncologist|February 24, 2018
Temozolomide Plus Bevacizumab in Elderly Patients with Newly Diagnosed Glioblastoma and Poor Performance Status: An ANOCEF Phase II Trial (ATAG)Germán Reyes-Botero, Stéphanie Cartalat-Carel, Olivier L Chinot, et al.Neuro-Oncology|May 16, 2020
Clinical, molecular, and radiomic profile of gliomas with FGFR3-TACC3 fusionsAnna Luisa Di Stefano, Alberto Picca, Edouard Saragoussi, et al.Pageof 21